Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan, D McQuaid… - Radiotherapy and …, 2012 - Elsevier
BACKGROUND: An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …
被引用次数：97 相关文章

Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan… - Radiotherapy and …, 2012 - thegreenjournal.com
Background An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …
[HTML] osti.gov

[HTML][HTML] Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan, D McQuaid… - Radiotherapy and …, 2012 - osti.gov
Background: An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …

[引用][C] Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan, D McQuaid… - Radiotherapy and …, 2012 - cir.nii.ac.jp
Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the
PARSPORT Phase III trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan, D McQuaid… - Radiotherapy and …, 2012 - infona.pl
An unexpected finding from the phase III parotid sparing radiotherapy trial, PARSPORT
(ISRCTN48243537, CRUK/03/005), was a statistically significant increase in acute fatigue …

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan… - … : journal of the …, 2012 - pubmed.ncbi.nlm.nih.gov
Background An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …
[PDF] academia.edu

[PDF][PDF] Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan… - Radiotherapy and …, 2012 - academia.edu
abstract Background: An unexpected finding from the phase III parotid sparing radiotherapy
trial, PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase …

Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

SL Gulliford, AB Miah, S Brennan, D McQuaid… - Radiotherapy and …, 2012 - inis.iaea.org
[en] Background: An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.

S Gulliford, AB Miah, S Brennan, D McQuaid… - … and oncology: journal …, 2012 - ora.ox.ac.uk
BACKGROUND: An unexpected finding from the phase III parotid sparing radiotherapy trial,
PARSPORT (ISRCTN48243537, CRUK/03/005), was a statistically significant increase in …

[引用][C] Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT phase III trial.

SL Gulliford, AB Miah, S Brennan… - Radiother …, 2012 - eprintspublications.npl.co.uk
Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the
PARSPORT phase III trial. | NPL Publications Home < back to main site Browse Search …